CTI BioPharma Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jul '25 Jul 31, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2016 - 2020
Market Capitalization	8,645	3,770	2,074	1,620	1,948	584	Upgrade
Market Cap Growth	93.87%	81.79%	28.04%	-16.85%	233.53%	-21.05%	Upgrade
Last Close Price	106.72	46.23	25.01	19.72	27.61	8.97	Upgrade
PE Ratio	151.52	79.95	54.34	110.48	199.42	70.99	Upgrade
PS Ratio	23.63	11.50	7.47	8.45	17.88	7.17	Upgrade
PB Ratio	16.36	7.26	4.06	3.56	10.76	7.81	Upgrade
P/FCF Ratio	75.23	43.39	28.09	44.58	104.87	23.59	Upgrade
P/OCF Ratio	72.27	42.73	27.48	43.86	101.65	23.13	Upgrade
Debt / Equity Ratio	0.12	0.09	0.08	0.11	0.11	0.08	Upgrade
Debt / FCF Ratio	0.54	0.52	0.54	1.36	1.04	0.25	Upgrade
Asset Turnover	0.59	0.54	0.49	0.49	0.67	0.93	Upgrade
Quick Ratio	3.17	2.81	2.32	1.34	2.60	2.94	Upgrade
Current Ratio	3.37	2.98	2.47	1.44	2.68	3.06	Upgrade
Return on Equity (ROE)	11.38%	9.16%	7.90%	4.61%	6.99%	12.62%	Upgrade
Return on Assets (ROA)	9.46%	7.74%	6.67%	3.77%	5.47%	10.06%	Upgrade
Earnings Yield	0.68%	1.25%	1.84%	0.91%	0.50%	1.41%	Upgrade
FCF Yield	1.33%	2.31%	3.56%	2.24%	0.95%	4.24%	Upgrade
Dividend Yield	0.45%	0.82%	1.30%	1.01%	0.36%	0.78%	Upgrade
Payout Ratio	52.48%	63.83%	55.60%	66.66%	54.00%	46.51%	Upgrade
Buyback Yield / Dilution	0.21%	-0.95%	-10.35%	-9.72%	-6.85%	-1.02%	Upgrade
Total Shareholder Return	0.66%	-0.12%	-9.05%	-8.71%	-6.49%	-0.24%	Upgrade

Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.